|
ELAN | Elanco Animal Health Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.61 |
| Leverage | 50.94% |
| Market Cap | $ 12.1B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -238.3m |
| Margin | -4.88% |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana.